93 related articles for article (PubMed ID: 17923046)
1. [The clinical value of the 99Tcm-MIBI imaging in predicting the prognosis of malignant lymphoma].
Qiao SK; Guo XN; Wang Y; Xu SR
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):2003-6. PubMed ID: 17923046
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of expression levels of multidrug resistance gene 1 (mdr1) mRNA, multidrug resistance-associated protein (MRP), amd P-glycoprotein (P-gp) with chemotherapy efficacy in malignant lymphomas].
Yang X; Jia L; Wei L; Zuo W; Song S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1177-9. PubMed ID: 12475404
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
[TBL] [Abstract][Full Text] [Related]
6. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
Br J Haematol; 2001 May; 113(2):369-74. PubMed ID: 11380401
[TBL] [Abstract][Full Text] [Related]
8. (99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors.
Sasajima T; Shimada N; Naitoh Y; Takahashi M; Hu Y; Satoh T; Mizoi K
Int J Cancer; 2007 Dec; 121(12):2637-45. PubMed ID: 17708555
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
Zhang XM; Zhang ZW; Wu H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
[TBL] [Abstract][Full Text] [Related]
10. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS
Oncology; 2006; 70(6):403-10. PubMed ID: 17237619
[TBL] [Abstract][Full Text] [Related]
11. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
12. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
13. Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression.
Liang JA; Shiau YC; Yang SN; Lin FJ; Lin CC; Kao A; Lee CC
Oncol Rep; 2002; 9(2):307-12. PubMed ID: 11836597
[TBL] [Abstract][Full Text] [Related]
14. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer].
Shi D; Huang G; Miao J; Lin X
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):824-7. PubMed ID: 12126530
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
[TBL] [Abstract][Full Text] [Related]
18. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
19. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
Song HC; Lee JJ; Bom HS; Chung IJ; Kim HJ; Park YK; Kim EE
Clin Nucl Med; 2003 Jun; 28(6):457-62. PubMed ID: 12911092
[TBL] [Abstract][Full Text] [Related]
20. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands.
Yamaguchi S; Yachiku S; Hashimoto H; Kaneko S; Nishihara M; Niibori D; Shuke N; Aburano T
World J Surg; 2002 Jan; 26(1):29-34. PubMed ID: 11898030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
